ASCO 2022: What investors should pay attention to at the year's biggest medical meeting
seekingalpha.com
finance
2022-05-28 20:00:00

stevegeer/iStock via Getty Images The 2022 American Society of Clinical Oncology Annual Meeting that begins June 3 is perhaps is the most eagerly anticipated medical meeting of the year. Thousands of abstracts and studies will be presented from pharma and biotech companies large and small. Some of the results are eagerly anticipated and have the potential to materially impact a company's stock. Here's a look at some presentations to look out for. AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo's (OTCPK:DSKYF) (OTCPK:DSNKY) Enhertu (trastuzumab) in HER2-low breast cancer.
